Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Overview of postpartum hemorrhage

INTRODUCTION

Postpartum hemorrhage (PPH) is an obstetrical emergency that can follow vaginal or cesarean delivery. It is a major cause of maternal morbidity, and one of the top three causes of maternal mortality in both high and low per capita income countries, although the absolute risk of death from PPH is much lower in high income countries (1 in 100,000 deliveries in the United Kingdom versus 1 in 1000 deliveries in the developing world). Hemorrhage is the most common reason postpartum women are admitted to intensive care units and arguably the most preventable cause of maternal mortality. Timely, accurate diagnosis is important to initiate appropriate interventions (eg, drugs, surgery, referral) and improve outcome [1].

INCIDENCE

The incidence of postpartum hemorrhage varies widely, depending upon criteria used to define the disorder. A reasonable estimate is 1 to 5 percent of deliveries [2]. In an analysis of population-based data from the United States National Inpatient Sample for the years 1994-2006, the discharge diagnosis of PPH increased 26 percent over this period (from 2.3 to 2.9 percent) [3]. Uterine atony was the most common cause of PPH and accounted for most of the increase. The proportion of women diagnosed with uterine atony increased from 1.6 to 2.4 percent over the 12 year period.

DEFINITION/DIAGNOSIS

PPH is defined as primary or secondary: primary PPH occurs in the first 24 hours after delivery (also called early PPH) and secondary PPH occurs 24 hours to 12 weeks after delivery (also called late or delayed PPH).

PPH is best defined/diagnosed clinically as excessive bleeding that makes the patient symptomatic (eg, pallor, lightheadedness, weakness, palpitations, diaphoresis, restlessness, confusion, air hunger, syncope) and/or results in signs of hypovolemia (eg, hypotension, tachycardia, oliguria, oxygen saturation <95 percent) (table 1). Heavy vaginal bleeding is usually noted, but vaginal bleeding may not be abnormal when hemorrhage is internal, for example, intraabdominal bleeding related to a cesarean delivery or a broad ligament or vaginal hematoma due to a sulcus laceration.

Other definitions for PPH that have been proposed have been problematic. The most common definition is estimated blood loss ≥500 mL after vaginal birth or ≥1000 mL after cesarean delivery. The inadequacy of this definition was illustrated in studies that assessed blood loss using various objective methods: the mean blood loss reported after vaginal and cesarean deliveries was approximately 400 to 600 mL and 1000 mL, respectively, and clinicians were likely to underestimate the volume of blood lost [4-6].

                        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Sep 16, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Prata N, Gerdts C. Measurement of postpartum blood loss. BMJ 2010; 340:c555.
  2. Lu MC, Fridman M, Korst LM, et al. Variations in the incidence of postpartum hemorrhage across hospitals in California. Matern Child Health J 2005; 9:297.
  3. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010; 202:353.e1.
  4. Andolina K, Daly S, Roberts N, et al. Objective measurement of blood loss at delivery: is it more than a guess. Am J Obstet Gynecol 1999; 180:S69.
  5. Ueland K. Maternal cardiovascular dynamics. VII. Intrapartum blood volume changes. Am J Obstet Gynecol 1976; 126:671.
  6. Stafford I, Dildy GA, Clark SL, Belfort MA. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol 2008; 199:519.e1.
  7. RCOG (2009) Postpartum haemorrhage, prevention and management. Green-top Guideline No. 52 http://www.rcog.org.uk/files/rcog-corp/GT52PostpartumHaemorrhage0411.pdf.
  8. Abdul-Kadir R, McLintock C, Ducloy AS, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion 2014; 54:1756.
  9. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 2010; 110:1368.
  10. Mhyre JM, Shilkrut A, Kuklina EV, et al. Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007. Obstet Gynecol 2013; 122:1288.
  11. Lockwood CJ, Schatz F. A biological model for the regulation of peri-implantational hemostasis and menstruation. J Soc Gynecol Investig 1996; 3:159.
  12. Lockwood CJ, Nemerson Y, Krikun G, et al. Steroid-modulated stromal cell tissue factor expression: a model for the regulation of endometrial hemostasis and menstruation. J Clin Endocrinol Metab 1993; 77:1014.
  13. Lockwood CJ. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells. Am J Obstet Gynecol 2001; 184:798.
  14. Lockwood CJ, Krikun G, Schatz F. The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol 1999; 17:45.
  15. Dildy GA 3rd. Postpartum hemorrhage: new management options. Clin Obstet Gynecol 2002; 45:330.
  16. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991; 77:69.
  17. Sheiner E, Sarid L, Levy A, et al. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med 2005; 18:149.
  18. Rouse DJ, Leindecker S, Landon M, et al. The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol 2005; 193:1056.
  19. Cheng YW, Delaney SS, Hopkins LM, Caughey AB. The association between the length of first stage of labor, mode of delivery, and perinatal outcomes in women undergoing induction of labor. Am J Obstet Gynecol 2009; 201:477.e1.
  20. Blomberg M. Maternal obesity and risk of postpartum hemorrhage. Obstet Gynecol 2011; 118:561.
  21. Wetta LA, Szychowski JM, Seals S, et al. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. Am J Obstet Gynecol 2013; 209:51.e1.
  22. Palmsten K, Hernández-Díaz S, Huybrechts KF, et al. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ 2013; 347:f4877.
  23. Kramer MS, Berg C, Abenhaim H, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol 2013; 209:449.e1.
  24. Sharp GC, Saunders PT, Greene SA, et al. Intergenerational transmission of postpartum hemorrhage risk: analysis of 2 Scottish birth cohorts. Am J Obstet Gynecol 2014; 211:51.e1.
  25. Oberg AS, Hernandéz-Diaź S, Frisell T, et al. Genetic contribution to postpartum haemorrhage in Swedish population: cohort study of 466,686 births. BMJ 2014; 349:g4984.
  26. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14:171.
  27. Kadir RA, Lee CA, Sabin CA, et al. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105:314.
  28. Kadir RA, Economides DL, Braithwaite J, et al. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997; 104:803.
  29. Myers B, Pavord S, Kean L, et al. Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency. BJOG 2007; 114:643.
  30. Santoro RC, Prejanò S. Postpartum-acquired haemophilia A: a description of three cases and literature review. Blood Coagul Fibrinolysis 2009; 20:461.
  31. Kadir RA, Kingman CE, Chi C, et al. Is primary postpartum haemorrhage a good predictor of inherited bleeding disorders? Haemophilia 2007; 13:178.
  32. Kadir RA, Aledort LM. Obstetrical and gynaecological bleeding: a common presenting symptom. Clin Lab Haematol 2000; 22 Suppl 1:12.
  33. Rizvi F, Mackey R, Barrett T, et al. Successful reduction of massive postpartum haemorrhage by use of guidelines and staff education. BJOG 2004; 111:495.
  34. Shields LE, Smalarz K, Reffigee L, et al. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. Am J Obstet Gynecol 2011; 205:368.e1.
  35. www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_30.htm. (Accessed on October 09, 2006).
  36. Novello, A, King, JC. Health Advisory: Prevention of Maternal Deaths Through Improved Managementof Hemorrhage. www.acog.org/acog_districts/dist_notice.cfm?recno=1&bulletin=1517. (Accessed on May 02, 2006).
  37. James AH, McLintock C, Lockhart E. Postpartum hemorrhage: when uterotonics and sutures fail. Am J Hematol 2012; 87 Suppl 1:S16.
  38. Turan J, Ojengbede O, Fathalla M, et al. Positive effects of the non-pneumatic anti-shock garment on delays in accessing care for postpartum and postabortion hemorrhage in Egypt and Nigeria. J Womens Health (Larchmt) 2011; 20:91.
  39. Miller S, Martin HB, Morris JL. Anti-shock garment in postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008; 22:1057.
  40. Sutherland T, Downing J, Miller S, et al. Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLoS One 2013; 8:e62282.
  41. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006; 108:1039.
  42. Hale TW, Baker TE. Use of methylergonovine in breastfeeding mothers. http://www.infantrisk.com/content/use-methylergonovine-breastfeeding-mothers-0 (Accessed on August 16, 2012).
  43. LactMed. Misoprostol http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~SjmV9q:1 (Accessed on November 07, 2013).
  44. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG 2006; 113:1248.
  45. Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited. Eur J Obstet Gynecol Reprod Biol 2005; 123 Suppl 2:S1.
  46. Perelló MF, Coloma JL, Masoller N, et al. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. BJOG 2014; 121:706.
  47. Kotto-Kome AC, Calhoun DA, Montenegro R, et al. Effect of administering recombinant erythropoietin to women with postpartum anemia: a meta-analysis. J Perinatol 2004; 24:11.
  48. Wågström E, Akesson A, Van Rooijen M, et al. Erythropoietin and intravenous iron therapy in postpartum anaemia. Acta Obstet Gynecol Scand 2007; 86:957.
  49. Milman N. Postpartum anemia II: prevention and treatment. Ann Hematol 2012; 91:143.
  50. Abdel-Razeq SS, Campbell K, Funai EF, et al. Normative postpartum intraabdominal pressure: potential implications in the diagnosis of abdominal compartment syndrome. Am J Obstet Gynecol 2010; 203:149.e1.
  51. Geerts WH, Code KI, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331:1601.
  52. Pacheco LD, Saade GR, Gei AF, Hankins GD. Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol 2011; 205:526.
  53. Doumouchtsis SK, Nikolopoulos K, Talaulikar V, et al. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG 2014; 121:382.
  54. Oberg AS, Hernandez-Diaz S, Palmsten K, et al. Patterns of recurrence of postpartum hemorrhage in a large population-based cohort. Am J Obstet Gynecol 2014; 210:229.e1.
  55. Ford JB, Roberts CL, Bell JC, et al. Postpartum haemorrhage occurrence and recurrence: a population-based study. Med J Aust 2007; 187:391.
  56. Alexander J, Thomas P, Sanghera J. Treatments for secondary postpartum haemorrhage. Cochrane Database Syst Rev 2002; :CD002867.
  57. Hoveyda F, MacKenzie IZ. Secondary postpartum haemorrhage: incidence, morbidity and current management. BJOG 2001; 108:927.
  58. Nanjundan P, Rohilla M, Raveendran A, et al. Pseudoaneurysm of uterine artery: a rare cause of secondary postpartum hemorrhage, managed with uterine artery embolisation. J Clin Imaging Sci 2011; 1:14.
  59. Yun SY, Lee DH, Cho KH, et al. Delayed postpartum hemorrhage resulting from uterine artery pseudoaneurysm rupture. J Emerg Med 2012; 42:e11.
  60. Hayata E, Matsuda H, Furuya K. Rare case of postpartum hemorrhage caused by rupture of a uterine artery pseudoaneurysm 3 months after Cesarean delivery. Ultrasound Obstet Gynecol 2010; 35:621.
  61. Marnela K, Saarelainen S, Palomäki O, Kirkinen P. Sonographic diagnosis of postpartum pseudoaneurysms of the uterine artery: a report of 2 cases. J Clin Ultrasound 2010; 38:205.
  62. Lausman AY, Ellis CA, Beecroft JR, et al. A rare etiology of delayed postpartum hemorrhage. J Obstet Gynaecol Can 2008; 30:239.
  63. Aziz N, Lenzi TA, Jeffrey RB Jr, Lyell DJ. Postpartum uterine arteriovenous fistula. Obstet Gynecol 2004; 103:1076.
  64. Yi SW, Ahn JH. Secondary postpartum hemorrhage due to a pseudoaneurysm rupture at the fundal area of the uterus: a case treated with selective uterine arterial embolization. Fertil Steril 2010; 93:2048.
  65. Gürses C, Yilmaz S, Biyikli S, et al. Uterine artery pseudoaneurysm: unusual cause of delayed postpartum hemorrhage. J Clin Ultrasound 2008; 36:189.
  66. Dewhurst CJ. Secondary post-partum haemorrhage. J Obstet Gynaecol Br Commonw 1966; 73:53.
  67. Thorsteinsson VT, Kempers RD. Delayed postpartum bleeding. Am J Obstet Gynecol 1970; 107:565.
  68. King PA, Duthie SJ, Dong ZG, Ma HK. Secondary postpartum haemorrhage. Aust N Z J Obstet Gynaecol 1989; 29:394.
  69. Mulic-Lutvica A, Axelsson O. Ultrasound finding of an echogenic mass in women with secondary postpartum hemorrhage is associated with retained placental tissue. Ultrasound Obstet Gynecol 2006; 28:312.
  70. Mulic-Lutvica A, Bekuretsion M, Bakos O, Axelsson O. Ultrasonic evaluation of the uterus and uterine cavity after normal, vaginal delivery. Ultrasound Obstet Gynecol 2001; 18:491.
  71. Edwards A, Ellwood DA. Ultrasonographic evaluation of the postpartum uterus. Ultrasound Obstet Gynecol 2000; 16:640.